- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.06. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.06. | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT at Hadassah University Medical Center in Israel | 237 | GlobeNewswire (Europe) | - First glioblastoma patient ever treated with Alpha DaRT® outside of the United States, and the first in Israel - performed at Hadassah University Medical Center in Jerusalem, one of the world's... ► Artikel lesen | |
| ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
| 15.06. | H.C. Wainwright reiterates Alpha Tau Medical stock rating on FDA trial clearance | 1 | Investing.com | ||
| 15.06. | H.C. Wainwright bestätigt Kaufempfehlung für Alpha Tau Medical nach FDA-Zulassung für Studie | 1 | Investing.com Deutsch | ||
| 11.06. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 11.06. | Alpha Tau Medical Ltd.: Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control | 306 | GlobeNewswire (Europe) | - Following the pre-specified interim safety report and overwhelming demand from clinicians to treat patients as quickly as possible, Alpha Tau to resume recruitment immediately for the remaining... ► Artikel lesen | |
| 03.06. | Alpha Tau teams with Tolmar on lucrative prostate cancer deal | 1 | Globes | ||
| 03.06. | Alpha Tau Medical Ltd.; Tolmar Inc.: Alpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT Therapy to U.S. Urological Cancer Patients | 2 | GlobeNewswire (USA) | ||
| 03.06. | H.C. Wainwright bestätigt Kaufempfehlung für Alpha Tau Medical nach Studiendaten | - | Investing.com Deutsch | ||
| 03.06. | H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial data | 1 | Investing.com | ||
| 01.06. | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | 526 | GlobeNewswire (Europe) | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| 01.06. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.05. | Barclays startet Coverage für Alpha Tau Medical mit "Overweight" | 1 | Investing.com Deutsch | ||
| 28.05. | Barclays initiates Alpha Tau Medical stock with overweight rating | 1 | Investing.com | ||
| 20.05. | H.C. Wainwright reiterates Buy on Alpha Tau stock, $15 target | 1 | Investing.com | ||
| 19.05. | Piper Sandler hebt Kursziel für Alpha Tau Medical nach Meilensteinen an | 2 | Investing.com Deutsch | ||
| 19.05. | Piper Sandler raises Alpha Tau Medical stock price target on milestones | 1 | Investing.com | ||
| 18.05. | Alpha Tau Medical GAAP EPS of -$0.26 | 3 | Seeking Alpha | ||
| 18.05. | Alpha Tau Medical Ltd.: Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update | 2.200 | GlobeNewswire (Europe) | - Groundbreaking interim results from U.S. REGAIN trial in recurrent glioblastoma demonstrate 100% local disease control, 67% complete response rate, and favorable safety profile - - Completion of... ► Artikel lesen | |
| 18.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings |
1 2 3 4 Weiter >>
63 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 1,850 | -1,07 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| BEYOND AIR | 0,465 | -0,64 % | Beyond Air Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update | Revenue increased by 107% year-over-year to $7.7 million in the full fiscal year 2026; increased revenue by 66% YoY in the fiscal fourth quarter 2026 The Company is transitioning its year-end from... ► Artikel lesen | |
| AXOGEN | 41,080 | +2,27 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| AETHLON MEDICAL | 0,720 | +1,41 % | AETHLON MEDICAL INC - S-1/A, General form for registration of securities | ||
| AVANOS MEDICAL | 22,000 | 0,00 % | Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger | ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced... ► Artikel lesen | |
| APYX MEDICAL | 3,700 | -7,96 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| ANGIODYNAMICS | 11,600 | 0,00 % | Reasons to Hold AngioDynamics Stock in Your Portfolio for Now | ||
| BLUEJAY DIAGNOSTICS | 1,130 | -0,88 % | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AESTHETIC MEDICAL INTERNATIONAL | 0,009 | 0,00 % | XFRA 3FMA,833: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAEST.MED.INT.HLD.SP.ADR/3... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 6,430 | 0,00 % | Autonomix Medical, Inc.: Autonomix Announces Reverse Stock Split | THE WOODLANDS, TX, June 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted... ► Artikel lesen | |
| BONE BIOLOGICS | 1,420 | 0,00 % | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| BAIRD MEDICAL | 1,190 | +0,85 % | BDMD: Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update | Full year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland China
Advancing global expansion with appointment of seasoned commercial leader... ► Artikel lesen | |
| AGAPE ATP | 2,830 | 0,00 % | Morning Market Movers: Intercont (Cayman), Agape ATP, Astrotech, Snowflake See Big Swings | TOKYO (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,800 | 0,00 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| BRAINSWAY | 15,190 | 0,00 % | Brainsway stock rating reiterated at Buy by H.C. Wainwright on PTSD data |
ALPHA TAU MEDICAL LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,04 % bei einem Aktienkurs von 13,225 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPHA TAU MEDICAL LTD finden Sie auf Wallstreet Online.